文献速递垂体与肾上腺疾病

原发性醛固酮增多症中皮质醇过多影响左心室肥厚

Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该研究纳入德国Conn注册中心慕尼黑中心的73例原发性醛固酮增多症患者(45例单侧醛固酮瘤,28例双侧肾上腺增生),采用气相色谱-质谱法测定24小时尿矿物皮质激素和糖皮质激素排泄,并用超声心动图评估基线和治疗1年后的心脏重构。结果显示85%患者诊断时存在左心室肥厚,左心室质量指数与总糖皮质激素排泄及四氢醛固酮排泄正相关;肾上腺切除术或盐皮质激素受体拮抗剂治疗均改善左心室质量指数,且该效果在高总糖皮质激素排泄患者中最明显。结论提示皮质醇过多对原发性醛固酮增多症患者的心脏重构有额外影响。

要点

  • 原发性醛固酮增多症患者中85%诊断时存在左心室肥厚。
  • 左心室质量指数与总糖皮质激素排泄及四氢醛固酮排泄正相关。
  • 肾上腺切除术或盐皮质激素受体拮抗剂治疗均改善左心室质量指数。

核心结论

  • 皮质醇过多似乎对原发性醛固酮增多症患者的心脏重构有额外影响。
  • 通过肾上腺切除术或盐皮质激素受体拮抗剂治疗原发性醛固酮增多症可改善左心室质量指数。
  • 该效果在高总糖皮质激素排泄患者中最明显。

研究设计与样本

  • 研究纳入德国Conn注册中心慕尼黑中心的73例原发性醛固酮增多症患者,其中45例单侧醛固酮瘤,28例双侧肾上腺增生。
  • 采用气相色谱-质谱法测定24小时尿矿物皮质激素和糖皮质激素排泄。
  • 采用超声心动图在基线和治疗开始1年后评估心脏重构。

主要发现

  • 诊断时85%的原发性醛固酮增多症患者根据左心室质量指数(中位数62.4 g/m2.7)存在左心室肥厚。
  • 左心室质量指数与总糖皮质激素排泄正相关(r2=0.076,P=0.018),与四氢醛固酮排泄正相关(r2=0.070,P=0.024)。
  • 肾上腺切除术使醛固酮瘤患者左心室质量指数显著降低(P<0.001),而盐皮质激素受体拮抗剂治疗双侧肾上腺增生患者左心室质量指数降低程度较小(P=0.024)。
  • 多变量分析中,左心室质量指数的下降与总糖皮质激素排泄和24小时收缩压正相关,但与四氢醛固酮排泄无关。

临床怎么用

  • 在原发性醛固酮增多症患者中应关注皮质醇共分泌,其可能加重心脏重构。
  • 肾上腺切除术或盐皮质激素受体拮抗剂治疗均可改善左心室质量指数,高总糖皮质激素排泄患者获益可能更明显。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary aldosteronism (PA) represents the most frequent form of endocrine hypertension. Hyperaldosteronism and hypercortisolism both induce excessive left ventricular hypertrophy (LVH) compared with matched essential hypertensives. In recent studies frequent cosecretion of cortisol and aldosterone has been reported in patients with PA. OBJECTIVE: Our aim was to investigate the impact of cortisol cosecretion on LVH in patients with PA. We determined 24-hour excretion of mineralocorticoids and glucocorticoids by gas chromatography-mass spectrometry and assessed cardiac remodeling using echocardiography initially and 1 year after initiation of treatment of PA. PATIENTS: We included 73 patients from the Munich center of the German Conn's registry: 45 with unilateral aldosterone-producing adenoma and 28 with bilateral adrenal hyperplasia. RESULTS: At the time of diagnosis, 85% of patients with PA showed LVH according to left ventricular mass index [(LVMI); median 62.4 g/m2.7]. LVMI correlated positively with total glucocorticoid excretion (r2 = 0.076, P = 0.018) as well as with tetrahydroaldosterone excretion (r2 = 0.070, P = 0.024). Adrenalectomy led to significantly reduced LVMI in aldosterone-producing adenoma (P < 0.001) whereas mineralocorticoid receptor antagonist therapy in bilateral adrenal patients with hyperplasia reduced LVMI to a lesser degree (P = 0.024). In multivariate analysis, the decrease in LVMI was positively correlated with total glucocorticoid excretion and systolic 24-hour blood pressure, but not with tetrahydroaldosterone excretion. CONCLUSION: Cortisol excess appears to have an additional impact on cardiac remodeling in patients with PA. Treatment of PA by either adrenalectomy or mineralocorticoid receptor antagonist improves LVMI. This effect was most pronounced in patients with high total glucocorticoid excretion.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Adolf C, Köhler A, Franke A, et al. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy. J Clin Endocrinol Metab. 2018. PMID: 30113683. doi:10.1210/jc.2018-00617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。